Taiwanese Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

General Biologicals

Market Cap: NT$973.2m

Engages in the research, development, manufacture, and sales of in-vitro diagnostics in Taiwan and internationally.

SynCore BiotechnologyLtd

Market Cap: NT$965.3m

Engages in development and sale of food advisory, medicine inspection, and biotechnology service in Taiwan.

SCI Pharmtech

Market Cap: NT$7.2b

Together with its subsidiary, engages in the research and development, manufacture, and sale of active pharmaceutical ingredients, intermediates, and specialty chemicals in Italy, the United States, Japan, Germany, Taiwan, Switzerland, China, and internationally.

YungShin Global Holding

Market Cap: NT$15.0b

Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics.

Anti-Microbial Savior BioteQ

Market Cap: NT$2.7b

Focuses on the research and development of pharmaceutical products in Taiwan.

Intech Biopharm

Market Cap: NT$3.2b

Engages in developing and manufacturing generic drugs to treat respiratory diseases in Taiwan and internationally.

Mercury Biopharmaceutical

Market Cap: NT$3.6b

Engages in the development of drugs for unmet needs in Taiwan.

AnnJi Pharmaceutical

Market Cap: NT$4.2b

Develops drugs in the therapeutic areas of neurology, dermatology, and inflammatory disorders.

UnicoCell Biomed

Market Cap: NT$4.7b

Engages in the research and development of stem cell drugs, cell therapy technology, and regenerative medical services in Taiwan.

RBC Bioscience

Market Cap: NT$256.2m

Researches, develops, manufactures, and sells reagents and devices for life science and molecular diagnosis in Europe, the United States, Asia, Taiwan, Africa, and Australia.

Yung Zip Chemical Ind

Market Cap: NT$923.7m

Yung Zip Chemical Ind. Co., Ltd., manufacturing, trading and sale of pharmaceuticals, pharmaceuticals, agricultural and industrial drugs, APIs, specialty chemicals and other related products internationally.

NeoCore Technology

Market Cap: NT$1.4b

Designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices.

Bioray Biotech

Market Cap: NT$739.6m

Engages in the research and development, manufacture, and sale of biological and health supplement products.

Locus Cell

Market Cap: NT$7.0b

Focuses on contract development and manufacturing organization (CDMO) services for cell products in Taiwan and internationally.

Adimmune

Market Cap: NT$7.5b

Engages in the development, manufacture, and distribution of vaccines and other biological products in Taiwan, the United States, China, and internationally.

Pharmigene

Market Cap: NT$582.9m

Designs, develops, manufactures, and sells diagnostic tests in Taiwan and internationally.

Foresee Pharmaceuticals

Market Cap: NT$12.6b

Operates as biopharmaceutical company in the United States, China, and Europe.

SunWay Biotech

Market Cap: NT$4.6b

Focuses on professional research and development, and technical material manufacturing and processing business.

Yoda Pharmaceuticals

Market Cap: NT$3.0b

An AI-driven company, focuses on advancing drug research and development targeting central nervous system disorders.

Sinphar PharmaceuticalLtd

Market Cap: NT$5.8b

Engages in the production, processing, selling, and trading of various medicines, Chinese medicines, medical cosmetic products and nutrients in Taiwan, Mainland China, Vietnam, Indonesia, and internationally.

Sunmax Biotechnology

Market Cap: NT$22.4b

A biomedical company, develops, manufactures, and markets collagen-based medical devices in Taiwan and Mainland China.

Orient EuroPharma

Market Cap: NT$4.5b

A pharmaceutical company, develops and manufactures drugs worldwide.

Protect Animal Health

Market Cap: NT$4.3b

Engages in the development of therapeutic vaccines for the animals.

HanchorBio

Market Cap: NT$9.9b

Operates as a biotechnology company that develops biologics for cancer patients.

Sunny Pharmtech

Market Cap: NT$2.9b

Engages in the research, development, and sale of new and generic drug in Taiwan, the United States, and internationally.

OBI Pharma

Market Cap: NT$8.3b

A clinical stage oncology company, research and develops novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally.

Taiwan Advance Bio-Pharmaceutical

Market Cap: NT$1.0b

Operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.

Kim Forest Enterprise

Market Cap: NT$1.2b

Provides various genetic and medical testing services in China and the United States.

Mycenax Biotech

Market Cap: NT$7.9b

Provides biopharmaceutical services and solutions for drug development and production in Taiwan.

Han.biomedical

Market Cap: NT$950.0m

Develops structured biomaterials for tissue regeneration in Taiwan.

Acepodia

Market Cap: NT$9.3b

Operates as a clinical stage biotechnology company.

Allied Biotech

Market Cap: NT$1.7b

Manufactures and sells carotenoids worldwide.

InnoPharmax

Market Cap: NT$2.4b

A specialty pharmaceutical company, develops and commercializes products for the treatment of oncology and other specialties in Taiwan.

AP Biosciences

Market Cap: NT$12.5b

A clinical-stage biopharmaceutical company, researches and develops bispecific antibody drugs for unmet medical needs.

Formosa Laboratories

Market Cap: NT$8.0b

Manufactures and sells active pharmaceutical ingredients (APIs) and ultraviolet absorbers in India, the Netherlands, Japan, Germany, Taiwan, China, Switzerland, the United States, Canada, and internationally.

UBI Pharma

Market Cap: NT$1.7b

UBI Pharma Inc. develops, manufactures, and sells pharmaceutical products in Taiwan.